罕见病知识库 RareSeen

重型先天性中性白细胞减少症

Severe congenital neutropenia

ORPHA:42738疾病组中国目录 第1批 · 104

定义 英文原文(暂无中文)

A rare primary immunodeficiency, without an associated lymphocyte deficit, characterized by impaired neutrophil maturation and/or function, associated with severe infections, diverse comorbidities, and/or an increased risk of leukemic transformation.

基本事实

遗传方式
常染色体显性、常染色体隐性、X 连锁隐性
发病年龄
儿童期
患病率
1-9 / 1 000 000(Europe)

相关基因 13来自下位疾病

Orphanet 未在本条目上直接标注致病基因。下表由本组所属的下位疾病汇总而来,「来源条目」列给出基因实际标注在哪一个 ORPHA 条目上。

基因名称来源条目
CLPBClpB family mitochondrial disaggregaseORPHA:486
CSF3Rcolony stimulating factor 3 receptorORPHA:420702
CXCR2C-X-C motif chemokine receptor 2ORPHA:420699
ELANEelastase, neutrophil expressedORPHA:486
G6PC3glucose-6-phosphatase catalytic subunit 3ORPHA:331176
GFI1growth factor independent 1 transcriptional repressorORPHA:486
HAX1HCLS1 associated protein X-1ORPHA:99749
JAGN1jagunal vesicle mediated transporter 1ORPHA:423384
SRP19signal recognition particle 19ORPHA:486
SRP54signal recognition particle 54ORPHA:675767
TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3ORPHA:486
VPS45vacuolar protein sorting 45 homologORPHA:369852
WASWASP actin nucleation promoting factorORPHA:86788

近两年的全球研究 243L2

2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-10开放获取
    Proteomic Signatures of Noise-Induced Hearing Loss in the Mouse Cochlea
    Cell biology international · DOI · Europe PMC
  • 2026-09
    Clinical outcome and infectious complications in genetic and suspected genetic neutropenia: A report from the Canadian Inherited Marrow Failure Registry
    British journal of haematology · DOI · Europe PMC
  • 2026-09开放获取
    GTPase cycle and ER membrane regulate cargo handover during cotranslational protein targeting
    Science advances · DOI · Europe PMC
  • 2026-09
    A yeast model for the functional analysis of SRP54 mutations associated with severe congenital neutropenia
    The FEBS journal · DOI · Europe PMC
  • 2026-09病例报告开放获取
    A Rare Case of Neonatal-Onset Diarrhea Due to Congenital Tufting Enteropathy: Clinical, Histopathological, and Genetic Insights
    Reports (MDPI) · DOI · Europe PMC
  • 2026-09
    Facial Phenotypic Pattern in Severe Congenital Neutropenia Type 4 (G6PC3 Deficiency): Description and Clinical Value
    Pediatric blood & cancer · DOI · Europe PMC
  • 2026-09
    Jagunal homolog 1 safeguards neutrophil immune function by preserving protein sialylation during differentiation
    Blood advances · DOI · Europe PMC
  • 2026-08病例报告开放获取
    Early-Onset TRNT1-Related SIFD Syndrome with an Additional Monoallelic C7 Variant: A Pediatric Case Report
    Diagnostics (Basel, Switzerland) · DOI · Europe PMC
  • 2026-08病例报告开放获取
    Prenatal diagnosis of glucose-6-phosphatase catalytic subunit 3 deficiency (Dursun syndrome) using whole-exome sequencing: A case report of severe fetal cardiomyopathy in a consanguineous family
    The Journal of international medical research · DOI · Europe PMC
  • 2026-08综述开放获取
    Innate immunity: current understandings and future perspectives
    Signal transduction and targeted therapy · DOI · Europe PMC
  • 2026-08开放获取
    Wiskott-Aldrich syndrome: clinical, immunological, and genetic characterization of the first Moroccan cohort
    Frontiers in pediatrics · DOI · Europe PMC
  • 2026-08综述
    Clinical pearls and pitfalls in inborn errors of immunity: An expert-derived framework for diagnostic pattern recognition
    Pediatric allergy and immunology : official publication of the Europea · 被引 1 · DOI · Europe PMC
  • 2026-08开放获取
    COPZ1 depletion induces cell death through different mechanisms in in vitro murine models of thyroid cancer
    European thyroid journal · DOI · Europe PMC
  • 2026-08
    TCR-αβ/CD 19 Depleted Graft Versus T Replete Graft With Post-Transplant Cyclophosphamide in Children Undergoing Haploidentical Donor Hematopoietic Stem Cell Transplantation for Inborn Errors of Immunity: A Comparative Analysis From India
    Pediatric transplantation · DOI · Europe PMC
  • 2026-07开放获取
    Clinical benefit, price and epidemiology of orphan drugs approved in China: a cross-sectional analysis of orphan drug policy (ODP) in China
    BMJ open · DOI · Europe PMC
  • 2026-07开放获取
    Targeting the HPV E6-p53 degradation axis via computational and <i>in vitro</i> identification of a repurposed small-molecule candidate
    Frontiers in oncology · DOI · Europe PMC
  • 2026-07综述开放获取
    Splenectomy revisited in Wiskott-Aldrich syndrome in the era of HSCT and gene therapy: a bridge, a rescue, or simply obsolete?
    Frontiers in immunology · DOI · Europe PMC
  • 2026-07开放获取
    J2R/F4L deleted oncolytic vaccinia virus synergizes with tumor specific killer (ELANE) promotes antitumor immunity with superior safety
    Frontiers in immunology · DOI · Europe PMC
  • 2026-07病例报告开放获取
    Palatal Perforation as a Rare Presentation of Severe Congenital Neutropenia Due to an ELANE Mutation
    Cureus · DOI · Europe PMC
  • 2026-07综述开放获取
    Fungal Infections in Disorders of Inborn Errors of Immunity
    Clinical reviews in allergy & immunology · DOI · Europe PMC

境外已获批用于本病的药物 0L2

欧盟与美国均未检索到已获批用于本病的药物。

尚未获批的在研药物(1 项)

这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。

  • mavorixafor美国2026-08-26
    该药获批用于体质性中性粒细胞减少症,本病属于其中
    treatment of congenital neutropenia
    官方记录

数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

中国境外的在招试验 5L2

这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。

美国5阿根廷1澳大利亚1比利时1加拿大1哥伦比亚1捷克1法国1Georgia1德国1希腊1匈牙利1印度1以色列1另有 11 个国家/地区

共 5 项。

  • 招募中NCT07066085
    Serial Blood Count Study
    早期 I 期 · 干预性 · 2024/10/17University of Washington
    美国
  • 招募中NCT06056297
    A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
    III 期 · 干预性 · 2024/06/06X4 Pharmaceuticals
    阿根廷、澳大利亚、比利时、加拿大、哥伦比亚、捷克、法国、Georgia 等 25 国
  • 招募中NCT06999954
    Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
    观察性 · 2024/02/07Shwachman-Diamond Syndrome Alliance Inc
    美国
  • 招募中NCT04099966
    AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
    II 期 · 干预性 · 2021/04/01Mitchell Cairo
    美国
  • 招募中NCT02720679
    Investigation of the Genetics of Hematologic Diseases
    观察性 · 2016/06/17St. Jude Children's Research Hospital
    美国

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)